Skip to main content
Premium Trial:

Request an Annual Quote

Genomics Shares Higher Following Celera Announcement

NEW YORK, Feb 12 – News that Celera had published its human genome sequencing paper in Science and made its data available on its website helped to bolster genomics stocks Monday morning.

Shares of Celera jumped 3.3, or 7.9 percent, to 44.90 in morning trading, while shares of sister company Applied Biosystems were also up, rising 3.49, or 4.8 percent, to 76.40.

Celera’s main competitor in the data war, Incyte, was also up, albeit a more moderate 5/16, or 1.5 percent, at 20 13/16.

Shares of genomics drug-discovery companies Human Genome Sciences and Millennium were also higher in morning trading. Shares of Human Genome Sciences jumped 3 1/4, or 6.4 percent, to 54 5/16. Millennium’s shares were up 2 1/16, or 5.0 percent, at 43.

Genomics technology companies were also higher following the reactions to the morning announcement. Bioinformatics player Lion Biosciences was up 1 1/4, or 2.2 percent, at 59 1/4, while DNA chipmaker Affymetrix was up 4 3/32, or 6.5 percent, at 66 11/16. 

But Third Wave Technologies, a maker of SNP detection tools, was down in its second day of trading. Shares were off 1/16, or 0.6 percent, at 11.

On Friday, Third Wave offered 7.5 million shares at $11 each. The company’s stock closed the day up 6 cents at $11.06.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.